Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

VELOCITY: An Anthrax Vaccine Clinical Study

ClinicalTrials.gov ID: NCT03877926

Public ClinicalTrials.gov record NCT03877926. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 10:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Parallel-group Trial to Evaluate the Lot Consistency, Immunogenicity, and Safety of AV7909 for Postexposure Prophylaxis of Anthrax in Healthy Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is designed to evaluate the lot consistency (using three consecutively manufactured lots), safety, and ability of the AV7909 anthrax vaccine to generate an immune response in healthy adults and compare the response to that induced by the currently licensed vaccine, BioThrax®, (Anthrax Vaccine Adsorbed; AVA) for post-exposure of anthrax disease.

Study identification

NCT ID
NCT03877926
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Emergent BioSolutions
Industry
Enrollment
3,689 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 11, 2019 (Actual)
Primary completion
Aug 6, 2020 (Actual)
Completion
Aug 6, 2020 (Actual)
Last update posted
May 6, 2026

2019 – 2020

United States locations

U.S. sites
35
U.S. states
20
U.S. cities
34
Facility City State ZIP Site status
Achieve Clinical Research, LLC Birmingham Alabama 35216 —
Optimal Research, LLC Huntsville Alabama 35802 —
Coastal Clinical Research, an AMR company Mobile Alabama 36608 —
Central Phoenix Medical Clinic, LLC Phoenix Arizona 85020 —
Clinical Research Consortium, an AMR company Tempe Arizona 85283 —
California Research Foundation San Diego California 92103 —
Optimal Research, LLC San Diego California 92108 —
Research Centers of America Hollywood Florida 33024 —
Optimal Research, LLC Melbourne Florida 32934 —
New Horizon Research Center, Inc Miami Florida 33175 —
Meridian Clinical Research, LLC Savannah Georgia 31406 —
Advanced Clinical Research Boise Idaho 83642 —
Christie Clinic, LLC Champaign Illinois 61820 —
Optimal Research, LLC Peoria Illinois 61614 —
The Iowa Clinic, PC West Des Moines Iowa 50266 —
Heartland Research Associates, LLC Augusta Kansas 67010 —
Hutchinson Clinic Hutchinson Kansas 67502 —
Johnson County Clin-Trials, LLC Lenexa Kansas 66219 —
Heartland Research Associates, LLC Wichita Kansas 67205 —
Benchmark Research New Orleans Metairie Louisiana 70006 —
Optimal Research, LLC Rockville Maryland 20850 —
The Center for Pharmaceutical Research, an AMR company Kansas City Missouri 64114 —
Meridian Clinical Research, LLC Omaha Nebraska 68134 —
Clinical Research Center of Nevada LLC Las Vegas Nevada 89104 —
Rapid Medical Research, Inc. Cleveland Ohio 44122 —
Aventiv Research Inc. Grove City Ohio 43123 —
Lynn Institute of Norman Norman Oklahoma 73072 —
Coastal Carolina Research Center, Inc Mt. Pleasant South Carolina 29464 —
Spartanburg Medical Research Spartanburg South Carolina 29303 —
Clinical Research Associates, Inc. Nashville Tennessee 37203 —
Tekton Research Austin Texas 78745 —
Benchmark Research Fort Worth Texas 76135 —
Benchmark Research San Angelo San Angelo Texas 76904 —
Martin Diagnostic Clinic Tomball Texas 77375 —
Advanced Clinical Research West Jordan Utah 84088 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03877926, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03877926 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →